EUVIMEDEUVIMED entdecken
Systematische Übersicht

L26/P-114 to discard or to not discard 2.1 PNs? a systematic review and evidence table analysis

A. Cecchele, B. Barbagallo, S. De Girolamo, L. Pagliardini, E. Papaleo, A. Bartolacci

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.450 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Cecchele und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Are 2.1PN-derived embryos euploid/diploid and suitable for embryo transfer? Summary answer Although 2.1PN-derived embryos exhibited lower developmental competence, they showed potential for healthy live births when biparental diploidy has been confirmed. What is known already Normal fertilization is defined by the presence of two pronuclei (2PN). However, some oocytes may exhibit atypical fertilization patterns, commonly referred to as atypically fertilized oocytes (AFOs), which are classified according to the number of visible pronuclei as 1PN, 3PN, or 2.1PN. In recent years, embryos originating from AFO have attracted increasing interest due to evidence suggesting that some may retain a diploid chromosomal complement and result in healthy live births. While the literature supporting the clinical use of embryos derived from 1PN zygotes is relatively extensive, the evidence concerning embryos derived from 2.1PN zygotes remains limited. Study design, size, duration PubMed was systematically searched for peer-reviewed original papers using relevant keywords and Medical Subject Heading terms. Primary outcomes included blastulation, euploid, and diploid rates. Secondary outcomes were blastocyst quality, clinical pregnancy, and live-birth rates. Participants/materials, setting, methods Studies assessing developmental competence and clinical outcomes from 2.1PN-derived embryos were included. Data were systematically extracted, focusing on blastulation, euploid, diploid, live birth, clinical pregnancy, and miscarriage rates. For each study, we identified absolute numbers (numerator and denominator) related to clinical outcomes. Finally, for each outcome, we calculated the percentage change between the control and study groups. Main results and the role of chance A total of 7 studies were included in the systematic review. Six out of seven studies indicated that 2.1PN embryos have lower developmental competence than 2PN embryos, yet can still be euploid/diploid, supporting their potential clinical use after PGT-A to confirm biparental diploidy. Only one study advised against their use for embryo transfer. In our analysis of the evidence tables, 2.1PN-derived embryos showed a reduction in blastulation rates (-23.87%), good-quality blastocyst formation (-12.14%), diploidy (-16.70%), and euploidy rates (-28.37%) when compared with their 2PN counterparts. Four studies also analyzed live births in 2.1PN, reporting an overall live birth rate of 30.4% (7/23). Moreover, by pooling three studies (total N = 500), we obtained a weighted mean small pronuclear diameter in 2.1PN embryos of 10.98 ± 2.3 µm (95% CI: 10.8-11.2 µm). Finally, based on the observed pooled blastulation (32.30%), euploidy (35.0%), and diploidy (82.0%) rates, the estimated probability for a single 2.1PN zygote to develop into a euploid/diploid blastocyst was 9.3%. Limitations, reasons for caution The major limitation of this analysis is represented by the observational nature of the studies (prospective or retrospective) included, but they are the only source of evidence available in literature. Wider implications of the findings Although 2.1PN-derived embryos exhibited lower developmental competence, they showed potential for healthy live births. Our findings support the cautious clinical use of 2.1PN-derived embryos when biparental diploidy has been confirmed, providing further empirical evidence to support more inclusive and flexible clinical recommendations, potentially improving cumulative success rates. Trial registration number No

Zitieren

APA

Cecchele, A., Barbagallo, B., Girolamo, S. D., Pagliardini, L., Papaleo, E., & Bartolacci, A. (2026). L26/P-114 to discard or to not discard 2.1 PNs? a systematic review and evidence table analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.450

Vancouver

Cecchele A, Barbagallo B, Girolamo SD, Pagliardini L, Papaleo E, Bartolacci A. L26/P-114 to discard or to not discard 2.1 PNs? a systematic review and evidence table analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.450

BibTeX
@article{Cecchele2026,
  author = {Cecchele, A. and Barbagallo, B. and Girolamo, S. De and Pagliardini, L. and Papaleo, E. and Bartolacci, A.},
  title = {L26/P-114 to discard or to not discard 2.1 PNs? a systematic review and evidence table analysis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.450}
}
Kostenlos starten →